News & Events
Newly Diagnosed with KRAS-Positive Lung Cancer?
Upcoming Events
Tue, 5/24/2022 - 12:00 PM ET
For patients/survivors - Join us every Tuesday for this general… more
Thu, 5/26/2022 - 8:00 PM CT
For caregivers, family & friends - You don’t need to take on… more
Fri, 5/27/2022 - 6:30 PM
For patients/survivors - General meetup moderated by survivors
After… more
Tue, 5/31/2022 - 12:00 PM ET
For patients/survivors - Join us every Tuesday for this general… more
May 17, 2022
Newly Diagnosed with KRAS-Positive Lung Cancer?
May 17, 2022
Newly Diagnosed with KRAS-Positive Lung Cancer?
LUNGevity's Amy Moore, PhD, sits down with Mark Awad, MD, PhD, a thoracic oncologist at Dana-Farber Cancer Institute, to discuss KRAS-positive lung cancer and what questions newly diagnosed patients should ask their doctors. We discuss first-line treatment, biomarker testing, clinical trials, and drug resistance.
May 17, 2022
An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
May 17, 2022
An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
May 17, 2022
Broader Testing Options Pave the Way for Increasingly Tailored Lung Cancer Treatments
May 17, 2022
Broader Testing Options Pave the Way for Increasingly Tailored Lung Cancer Treatments
May 9, 2022
All Things KRAS: A Conversation with Terri Conneran and Dr. Darryl McConnell
May 9, 2022
All Things KRAS: A Conversation with Terri Conneran and Dr. Darryl McConnell
On January 31, 2022, Amy Moore, PhD, brought us an update on KRAS. Dr. Moore, LUNGevity's Vice President of Global Engagement and Patient Partnerships, spoke with Terri Conneran, KRAS lung cancer survivor and founder of the KRAS Kickers; and Darryl McConnell, PhD, Research Site Head at Boehringer Ingelheim in Vienna, Austria.
May 9, 2022
Tracing Tumor Evolution Through Single-Cell Changes Could Provide Therapeutic Windows
May 9, 2022
Tracing Tumor Evolution Through Single-Cell Changes Could Provide Therapeutic Windows
May 9, 2022
A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients
May 9, 2022
A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients
May 2, 2022
Tips for Better Sleep
May 2, 2022
Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer
May 2, 2022
Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer
May 2, 2022
Sotorasib Provides Durable Clinical Benefit for Patients wit
May 1, 2022